Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,778 | 149 | 86.1% |
| Education | $363.97 | 4 | 11.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85.00 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $555.15 | 23 | $0 (2020) |
| Janssen Biotech, Inc. | $526.24 | 28 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $407.14 | 22 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $311.46 | 13 | $0 (2020) |
| GENZYME CORPORATION | $243.95 | 13 | $0 (2020) |
| Astellas Pharma US Inc | $239.90 | 8 | $0 (2020) |
| PFIZER INC. | $211.15 | 7 | $0 (2020) |
| Endo Pharmaceuticals Inc. | $117.91 | 8 | $0 (2019) |
| Blue Earth Diagnostics Limited | $110.42 | 5 | $0 (2021) |
| Mylan Institutional Inc. | $67.03 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $68.84 | 3 | Blue Earth Diagnostics Limited ($23.22) |
| 2020 | $735.87 | 37 | Janssen Biotech, Inc. ($181.30) |
| 2019 | $712.31 | 38 | Bayer HealthCare Pharmaceuticals Inc. ($192.87) |
| 2018 | $1,067 | 46 | Amgen Inc. ($216.61) |
| 2017 | $643.12 | 32 | Amgen Inc. ($134.30) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/29/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Oncology | ||||||
| 01/25/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: HORMONE THERAPY | ||||||
| 01/18/2021 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Diagnostic Imaging | ||||||
| 12/07/2020 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Oncology | ||||||
| 11/20/2020 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Oncology | ||||||
| 11/16/2020 | Myriad Genetic Laboratories, Inc. | BRACANALYSIS CDX (Device) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: GERMLINE DNA SEQUENCING HEREDITARY CANCER AND REARRANGEMENT ANALYSIS | ||||||
| 11/13/2020 | Merck Sharp & Dohme Corporation | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: UROLOGY | ||||||
| 11/02/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $64.99 | General |
| Category: Oncology | ||||||
| 11/02/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Oncology | ||||||
| 10/26/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/12/2020 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONFOCUS | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: ONCOLOGY | ||||||
| 09/28/2020 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Oncology | ||||||
| 09/21/2020 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Diagnostic Imaging | ||||||
| 09/14/2020 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Oncology | ||||||
| 08/29/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Oncology | ||||||
| 08/24/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Oncology | ||||||
| 08/17/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/10/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/29/2020 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Bone Health | ||||||
| 06/18/2020 | Mylan Institutional Inc. | Fulphila (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Oncology | ||||||
| 06/15/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/08/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 115 | 133 | $24,900 | $6,212 |
| 2021 | 24 | 958 | 2,310 | $153,276 | $49,545 |
| 2020 | 44 | 7,426 | 43,160 | $2.6M | $919,650 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $9,089 | $2,085 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 41 | $7,339 | $1,904 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 39 | $4,836 | $1,573 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $3,636 | $649.84 | 17.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 12 | 1,320 | $36,300 | $21,233 | 58.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 93 | 97 | $31,525 | $8,397 | 26.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 17 | 39 | $29,250 | $6,686 | 22.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2021 | 67 | 67 | $6,030 | $1,706 | 28.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 85 | 87 | $5,220 | $1,563 | 29.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 34 | 35 | $10,500 | $1,370 | 13.0% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2021 | 36 | 36 | $2,160 | $980.66 | 45.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 16 | $7,200 | $896.46 | 12.5% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2021 | 36 | 36 | $2,160 | $762.70 | 35.3% |
| 84066 | Phosphatase, prostatic (prostate enzyme) level | Office | 2021 | 68 | 70 | $2,450 | $667.49 | 27.2% |
| 83001 | Gonadotropin, follicle stimulating (reproductive hormone) level | Office | 2021 | 36 | 36 | $2,700 | $653.05 | 24.2% |
| 83002 | Gonadotropin, luteinizing (reproductive hormone) level | Office | 2021 | 36 | 36 | $2,700 | $650.94 | 24.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 70 | 72 | $1,728 | $601.91 | 34.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 73 | 77 | $1,925 | $591.67 | 30.7% |
| 80076 | Liver function blood test panel | Office | 2021 | 68 | 70 | $1,540 | $564.54 | 36.7% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 17 | 17 | $2,465 | $473.84 | 19.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 26 | 26 | $2,210 | $348.14 | 15.8% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2021 | 15 | 15 | $750.00 | $254.10 | 33.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 15 | 15 | $825.00 | $252.00 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 81 | 83 | $1,265 | $249.00 | 19.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 14 | 14 | $588.00 | $211.12 | 35.9% |
About Dr. Jeffrey Turner, M.D
Dr. Jeffrey Turner, M.D is a Internal Medicine healthcare provider based in Lake Oswego, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205855913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Turner, M.D has received a total of $3,227 in payments from pharmaceutical and medical device companies, with $68.84 received in 2021. These payments were reported across 156 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,778).
As a Medicare-enrolled provider, Turner has provided services to 8,499 Medicare beneficiaries, totaling 45,603 services with total Medicare billing of $975,407. Data is available for 3 years (2020–2022), covering 72 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Specialist
- Location Lake Oswego, OR
- Active Since 07/19/2006
- Last Updated 12/03/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205855913
Products in Payments
- XTANDI (Drug) $361.67
- PROVENGE (Drug) $333.42
- Xofigo (Drug) $276.47
- Erleada (Drug) $201.80
- ERLEADA (Drug) $181.30
- JEVTANA (Drug) $158.95
- Neulasta (Biological) $154.81
- ZYTIGA (Drug) $143.14
- Nubeqa (Drug) $130.67
- Prolia (Biological) $130.27
- Axumin (Drug) $110.42
- ELITEK (Drug) $85.00
- AVEED (Biological) $74.93
- Fulphila (Biological) $67.03
- Xtandi (Drug) $63.03
- EVENITY (Biological) $56.47
- Aranesp (Biological) $55.99
- TESTOPEL (Drug) $42.98
- XGEVA (Biological) $35.17
- Lupron (Drug) $33.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lake Oswego
Hidenao Kimura, Md, MD
Internal Medicine — Payments: $9,561
Steven Hashiguchi, Md, MD
Internal Medicine — Payments: $2,736
Dr. Lauren Gearhart, Md, MD
Internal Medicine — Payments: $2,242
Jordan Smith, M.d, M.D
Internal Medicine — Payments: $1,999
Dr. Daryl Baron, Md, MD
Internal Medicine — Payments: $1,624
Dr. Ellen Mayock, Md, MD
Internal Medicine — Payments: $251.68